Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marinomed Biotech AG (DE:93Z)
FRANKFURT:93Z
Marinomed Biotech AG (93Z) Stock Price & Analysis
0 Followers
93Z Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€10.30 - €43.90
Previous Close€11.1
Volume0.00
Average Volume (3M)106.00
Market Cap
€17.56M
Enterprise Value€32.01M
Total Cash (Recent Filing)€8.18M
Total Debt (Recent Filing)€22.63M
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Aug 20, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.50
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume106
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
93Z FAQ
What was Marinomed Biotech AG’s price range in the past 12 months?
Marinomed Biotech AG lowest stock price was €10.30 and its highest was €43.90 in the past 12 months.
What is Marinomed Biotech AG’s market cap?
Currently, no data Available
When is Marinomed Biotech AG’s upcoming earnings report date?
Marinomed Biotech AG’s upcoming earnings report date is Aug 20, 2024 which is in 27 days.
How were Marinomed Biotech AG’s earnings last quarter?
Currently, no data Available
Is Marinomed Biotech AG overvalued?
According to Wall Street analysts Marinomed Biotech AG’s price is currently Overvalued.
Does Marinomed Biotech AG pay dividends?
Marinomed Biotech AG does not currently pay dividends.
What is Marinomed Biotech AG’s EPS estimate?
Marinomed Biotech AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marinomed Biotech AG have?
Marinomed Biotech AG has 1,540,530 shares outstanding.
What happened to Marinomed Biotech AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Marinomed Biotech AG?
Currently, no hedge funds are holding shares in DE:93Z
---
Marinomed Biotech AG Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-37.62%
Trailing 12-Months
Company Description
Marinomed Biotech AG
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal spray, virus-blocking lozenges and virus-blocking throat spray.
---
Technical Analysis
---